The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and compliance data of the phase III study of adjuvant chemotherapy for patients (pts) with completely resected, pathological (p-) stage I (T1 > 2 cm) non-small cell lung cancer (NSCLC): A Japan Clinical Oncology Group Trial, JCOG0707.
 
Hideo Kunitoh
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; Dainippon Sumitomo Pharma; Johnson & Johnson; Lilly Japan; MSD; Novo Nordisk; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Taiho Pharmaceutical
 
Masahiro Tsuboi
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Covidien; Daiichi Sankyo; Johnson & Johnson; Lilly Japan; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst)
 
Hiroyuki Sakurai
No Relationships to Disclose
 
Masashi Wakabayashi
No Relationships to Disclose
 
Morihito Okada
Speakers' Bureau - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
 
Kenji Suzuki
Speakers' Bureau - Chugai Pharma; Covidien; Ethicon; Taiho Pharmaceutical
Research Funding - Chugai Pharma (Inst); Covidien; Shionogi (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Chugai Pharma; Covidien; Ethicon; Taiho Pharmaceutical
 
Norihiko Ikeda
Honoraria - AstraZeneca; Chugai Pharma; Olympus; Taiho Pharmaceutical
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Lilly (Inst); Taiho Pharmaceutical (Inst)
 
Mitsuhiro Takenoyama
Research Funding - Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Lilly Japan (Inst); Nippon Boehringer Ingelheim (Inst); Novartis (Inst); Ono Pharmaceutical (Inst)
 
Yasuhisa Ohde
No Relationships to Disclose
 
Makoto Takahama
Speakers' Bureau - Johnson & Johnson
 
Katsuo Yoshiya
No Relationships to Disclose
 
Isao Matsumoto
No Relationships to Disclose
 
Motohiro Yamashita
No Relationships to Disclose
 
Takashi Marutsuka
No Relationships to Disclose
 
Hiroshi Date
Honoraria - Taiho Pharmaceutical
 
Yasuki Saito
No Relationships to Disclose
 
Yoshinori Yamashita
No Relationships to Disclose
 
Norihito Okumura
Honoraria - Taiho Pharmaceutical
 
Shun-ichi Watanabe
Honoraria - Covidien; Johnson & Johnson
 
Hisao Asamura
Honoraria - Johnson & Johnson; Medtronic
Consulting or Advisory Role - Medtronic